Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Dyne Therapeutics Inc shares valued at $1,002,751 were sold by Beskrovnaya Oxana on May 20 ’24. At $32.96 per share, Beskrovnaya Oxana sold 30,426 shares. The insider’s holdings dropped to 149,647 shares worth approximately $4.68 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, McNeill Jonathan sold 2,774 shares, netting a total of over 78,420 in proceeds. Following the sale of shares at $28.27 each, the insider now holds 136,634 shares.
Before that, HIGH SUSANNA GATTI had sold 2,738 shares from its account. In a trade valued at $77,402, the Chief Operating Officer traded Dyne Therapeutics Inc shares for $28.27 each. Upon closing the transaction, the insider’s holdings decreased to 2,738 shares, worth approximately $4.81 million.
As published in a research note from Chardan Capital Markets on May 21, 2024, Dyne Therapeutics Inc [DYN] has been retained to a Buy and the price target has been revised to $42. Analysts at Morgan Stanley started covering the stock with ‘”an Overweight”‘ outlook in a report released in late April. As of February 20, 2024, H.C. Wainwright has initiated its “Buy” rating for DYN. Earlier on February 27, 2023, Raymond James upgraded its rating. Their new recommendation was “a Strong buy” for DYN stock which previously was a “an Outperform”.
Analyzing DYN Stock Performance
During the last five days, there has been a surge of approximately 8.70%. Over the course of the year, Dyne Therapeutics Inc shares have jumped approximately 134.96%. Shares of the company reached a 52-week high of $35.98 on 05/21/24 and a 52-week low of $12.33 on 01/03/24. A 50-day SMA is recorded $27.02, while a 200-day SMA reached $17.15. Nevertheless, trading volume fell to 2.64 million shares from 6.69 million shares the previous day.
Support And Resistance Levels for Dyne Therapeutics Inc (DYN)
According to the 24-hour chart, there is a support level at 30.77, which, if violated, would cause prices to drop to 30.28. In the upper region, resistance lies at 31.90. The next price resistance is at 32.54. RSI (Relative Strength Index) is 60.27 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.17, which suggests the price will increase in the coming days. Percent R is at 42.81%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
